BUSINESS WIRE)--Northstar Neuroscience, Inc. (NASDAQ:NSTR) today reported that investments in ongoing clinical trials and continued development of its cortical stimulation platform resulted in a net loss of $4.9 million and $23.9 million for the quarter and year ended December 31, 2007, respectively, compared to a net loss of $5.3 million and $25.1 million for the quarter and year ended December 31, 2006, respectively. The Company also reported cash and investments of $83.5 million at December 31, 2007 compared to $105.3 million at December 31, 2006.
